1 | F 18 T807 | - | - | - | - | 2件: 2 2, 127 💬
|
2 | F-18 | - | - | - | - | 3件: 5 5, 7, 127 💬
|
3 | F-18 3f4AP | - | - | - | - | 1件: 13 13 💬
|
4 | F-18 AV 1451 | - | - | - | - | 2件: 5 5, 127 💬
|
5 | F-18 FDG | - | - | - | - | 1件: 127 127 💬
|
6 | F-18 fpcit | - | - | - | - | 1件: 6 6 💬
|
7 | F-dopa PET CT | - | - | - | - | 1件: 75 75 💬
|
8 | F13CD | - | - | - | - | 1件: 288 288 💬
|
9 | F18-AV-45 | - | - | - | - | 1件: 6 6 💬
|
10 | F18ceto | - | - | - | - | 1件: 75 75 💬
|
11 | F8il10 | - | - | - | - | 2件: 46 46, 97 💬
|
12 | F8VR | - | - | - | - | 1件: 288 288 💬
|
13 | FAB122 | - | - | - | - | 1件: 2 2 💬
|
14 | Fabrazyme | 1件: Agalsidase beta Agalsidase beta | 1件: Agalsidase beta
Agalsidase beta
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
15 | Fabrazyme (agalsidase beta) 1 MG/KG | 1件: Agalsidase beta Agalsidase beta | 1件: Agalsidase beta
Agalsidase beta
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
16 | Fabrazyme - 35 MG polvere PER concentrato PER soluzione PER infusione endovenosa 1 flaconcino | 1件: Agalsidase beta Agalsidase beta | 1件: Agalsidase beta
Agalsidase beta
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
17 | Fabrazyme 35 MG | 1件: Agalsidase beta Agalsidase beta | 1件: Agalsidase beta
Agalsidase beta
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
18 | Fabrazyme 5 MG | 1件: Agalsidase beta Agalsidase beta | 1件: Agalsidase beta
Agalsidase beta
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
19 | Facs analyses | - | - | - | - | 1件: 65 65 💬
|
20 | Factane 200 IU/ML | - | - | - | - | 1件: 288 288 💬
|
21 | Factor viii concentrate | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 💬
|
22 | Factor VON willebrand | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 💬
|
23 | Factor X | 1件: Coagulation factor X human Coagulation factor X human | - | - | - | 1件: 288 288 💬
|
24 | Factor xiia antagonist monoclonal antibody | - | - | - | - | 2件: 65 65, 85 💬
|
25 | Factor xiia inhibitor monoclonal antibody | - | - | - | - | 1件: 65 65 💬
|
26 | Factor xiii | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 3件: 51 51, 97, 288 💬
|
27 | Factor xiii concentrate (human), pasteurized | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 1件: 288 288 💬
|
28 | Faecal bacterial transplantation | - | - | - | - | 1件: 97 97 💬
|
29 | Faecal matter | - | - | - | - | 1件: 97 97 💬
|
30 | Faecal microbiota transplant | - | - | - | - | 2件: 94 94, 97 💬
|
31 | Faecal microbiota transplantation | - | - | - | - | 5件: 46 46, 84, 96, 97, 271 💬
|
32 | Faecal sampling | - | - | - | - | 1件: 46 46 💬
|
33 | FAM therapy | - | - | - | - | 1件: 228 228 💬
|
34 | FAMC-1 | - | - | - | - | 1件: 2 2 💬
|
35 | Famciclovir | 1件: Famciclovir Famciclovir | 1件: Famciclovir
Famciclovir
💬
| - | - | 2件: 11 11, 13 💬
|
36 | Famotidina | 1件: Famotidine Famotidine | 1件: Famotidine
Famotidine
💬
| 1件: HRH2 HRH2 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 61 61 💬
|
37 | Famotidine | 1件: Famotidine Famotidine | 1件: Famotidine
Famotidine
💬
| 1件: HRH2 HRH2 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 5件: 6 6, 46, 98, 145, 300 💬
|
38 | Famotidine 20 MG | 1件: Famotidine Famotidine | 1件: Famotidine
Famotidine
💬
| 1件: HRH2 HRH2 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 86 86 💬
|
39 | Fampridina | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
40 | Fampridine | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 13 13, 14 💬
|
41 | Fampridine SR | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
42 | Fampridine-SR | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
43 | Fampyra | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 13 13, 14 💬
|
44 | Fampyra 10 MG prolonged-release tablets | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
45 | Fampyra 10MG prolonged release tablets | - | - | - | - | 1件: 13 13 💬
|
46 | FAN beam CT scan | - | - | - | - | 1件: 49 49 💬
|
47 | Fang | 1件: Gemogenovatucel-T Gemogenovatucel-T | - | - | - | 1件: 46 46 💬
|
48 | Fang YI qing feng SHI granule | - | - | - | - | 1件: 46 46 💬
|
49 | Fanhdi | - | - | - | - | 1件: 288 288 💬
|
50 | Fanhdi 100 UI | - | - | - | - | 1件: 288 288 💬
|
51 | Fanhdi 100 UI fviii-120 UI FVW | - | - | - | - | 1件: 288 288 💬
|
52 | Fanhdi 25 UI | - | - | - | - | 1件: 288 288 💬
|
53 | Fanhdi 25 UI fviii-30 UI FVW | - | - | - | - | 1件: 288 288 💬
|
54 | Fanhdi 250UI*1F 250UI+F 10ML | - | - | - | - | 1件: 288 288 💬
|
55 | Fanhdi 50 UI | - | - | - | - | 1件: 288 288 💬
|
56 | Fanhdi 50 UI fviii-60 UI FVW | - | - | - | - | 1件: 288 288 💬
|
57 | Fanhdi*INF FL 250UI+SIR solv+S | - | - | - | - | 1件: 288 288 💬
|
58 | Fanhdi*INF FL 500UI+SIR solv+S | - | - | - | - | 1件: 288 288 💬
|
59 | Fanhdi*INF FL1000UI+SIR solv+S | - | - | - | - | 1件: 288 288 💬
|
60 | Fanhdi*INF FL250UI+SIR solv+S | - | - | - | - | 1件: 288 288 💬
|
61 | Fasenra | 1件: Benralizumab Benralizumab | 1件: Benralizumab
Benralizumab
💬
| 1件: IL5RA IL5RA 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 5件: 44 44, 45, 98, 162, 299 💬
|
62 | Fasting blood test | - | - | - | - | 1件: 6 6 💬
|
63 | Fasudil | 1件: Fasudil Fasudil | 2件: Fasudil hydrochloride
Fasudil hydrochloride
,
Fasudil
💬
| 2件: ROCK1 ROCK1, ROCK2 💬
| 24件: Adherens junction Adherens junction, Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 2 2, 5, 7, 51 💬
|
64 | Fasudil hydrochloride | 1件: Fasudil Fasudil | 2件: Fasudil hydrochloride
Fasudil hydrochloride
,
Fasudil
💬
| 2件: ROCK1 ROCK1, ROCK2 💬
| 24件: Adherens junction Adherens junction, Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 2 2, 6 💬
|
65 | FAT soluble vitamins supplementation | - | - | - | - | 1件: 299 299 💬
|
66 | FAT stem cell | - | - | - | - | 1件: 96 96 💬
|
67 | Fatigue | - | - | - | - | 1件: 13 13 💬
|
68 | Fatigue and daytime sleepiness scale | - | - | - | - | 1件: 113 113 💬
|
69 | Faxe kondi free | - | - | - | - | 1件: 257 257 💬
|
70 | Fazirsiran | 1件: Fazirsiran Fazirsiran | - | - | - | 1件: 231 231 💬
|
71 | Fazirsiran (TAK-999, also referred TO AS ARO-AAT) injection | 1件: Fazirsiran Fazirsiran | - | - | - | 1件: 231 231 💬
|
72 | Fazirsiran (TAK-999, ARO-AAT) injection | 1件: Fazirsiran Fazirsiran | - | - | - | 1件: 231 231 💬
|
73 | Fazisiran injection | - | - | - | - | 1件: 231 231 💬
|
74 | FB-101 | 1件: FB-101 FB-101 | - | - | - | 1件: 6 6 💬
|
75 | FB1006 | - | - | - | - | 1件: 2 2 💬
|
76 | FB418 | - | - | - | - | 2件: 2 2, 6 💬
|
77 | FB704A | - | - | - | - | 1件: 46 46 💬
|
78 | FBL-MTX | - | - | - | - | 1件: 46 46 💬
|
79 | FBS0701 capsule | - | - | - | - | 1件: 284 284 💬
|
80 | FBS0701/SSP004184 | - | - | - | - | 1件: 284 284 💬
|
81 | FBX-101 | 1件: FBX-101 FBX-101 | - | - | - | 1件: 19 19 💬
|
82 | FC- and CDR-modified humanised monoclonal antibody against C5 | - | - | - | - | 3件: 11 11, 62, 109 💬
|
83 | FCM | - | - | - | - | 1件: 222 222 💬
|
84 | FCN-159 | - | - | - | - | 1件: 34 34 💬
|
85 | FCR blocker OF autoantibodies | - | - | - | - | 1件: 51 51 💬
|
86 | FCR001 | 1件: FCR001 FCR001 | - | - | - | 1件: 51 51 💬
|
87 | FCX-007 | - | - | - | - | 1件: 36 36 💬
|
88 | FCX-007 (dabocemagene autoficel | - | - | - | - | 1件: 36 36 💬
|
89 | FCX-013 | 1件: FCX-013 FCX-013 | - | - | - | 1件: 51 51 💬
|
90 | FDC macitentan/tadalafil | 2件: Macitentan Macitentan, Tadalafil | 2件: Tadalafil
Tadalafil
,
Macitentan
💬
| 3件: EDNRA EDNRA, EDNRB, PDE5 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
91 | FDG | - | - | - | - | 2件: 41 41, 84 💬
|
92 | FDG PET scan | - | - | - | - | 2件: 6 6, 85 💬
|
93 | FDG-PET | - | - | - | - | 3件: 5 5, 6, 7 💬
|
94 | FDG-PET/CT with RB82 myocardial perfusion imaging | - | - | - | - | 1件: 84 84 💬
|
95 | FDL169 | 1件: FDL169 FDL169 | - | - | - | 1件: 299 299 💬
|
96 | FDL176 | - | - | - | - | 1件: 299 299 💬
|
97 | FDL176 & FDL169 coadministration | - | - | - | - | 1件: 299 299 💬
|
98 | FE 992097 | - | - | - | - | 1件: 193 193 💬
|
99 | FE 999301 | - | - | - | - | 2件: 96 96, 97 💬
|
100 | Fear OF falling | - | - | - | - | 1件: 13 13 💬
|
101 | Feasibility OF BETA-hydroxybutyrate supplementation TO reduce inflammation IN patients with crohn'S | - | - | - | - | 2件: 96 96, 97 💬
|
102 | Feburane | - | - | - | - | 1件: 21 21 💬
|
103 | Febuxostat | 1件: Febuxostat Febuxostat | 2件: Febuxostat
Febuxostat
,
Febuxostat hydrate
💬
| 1件: XDH XDH 💬
| 4件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | 4件: 2 2, 6, 13, 97 💬
|
104 | Fecal microbial L transplantation | - | - | - | - | 1件: 97 97 💬
|
105 | Fecal microbial transplant | - | - | - | - | 3件: 46 46, 96, 97 💬
|
106 | Fecal microbial transplantation | - | - | - | - | 2件: 96 96, 97 💬
|
107 | Fecal microbial transplants | - | - | - | - | 1件: 13 13 💬
|
108 | Fecal microbiome | - | - | - | - | 1件: 61 61 💬
|
109 | Fecal microbiome probiotic | - | - | - | - | 1件: 294 294 💬
|
110 | Fecal microbiota | 1件: Fecal microbiota Fecal microbiota | - | - | - | 5件: 13 13, 49, 93, 96, 97 💬
|
111 | Fecal microbiota capsule | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 97 97 💬
|
112 | Fecal microbiota enema | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 97 97 💬
|
113 | Fecal microbiota transfer provided BY human biome institute | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 6 6 💬
|
114 | Fecal microbiota transplant | 1件: Fecal microbiota Fecal microbiota | - | - | - | 3件: 6 6, 96, 97 💬
|
115 | Fecal microbiota transplantation | 1件: Fecal microbiota Fecal microbiota | - | - | - | 10件: 2 2, 6, 13, 63, 66, 94, 96, 97, 99, 271 💬
|
116 | Fecal microbiota transplantation (FMT) OF FMP30 donor stool | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 13 13 💬
|
117 | Fecal microbiota transplantation (FMT), openbiome | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 97 97 💬
|
118 | Fecal microbiota transplantation BY intra-rectal enemas | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 97 97 💬
|
119 | Fecal microbiota transplantation BY stool capsules | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 97 97 💬
|
120 | Fecal microbiota transplantation capsules | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 97 97 💬
|
121 | Fecal transplantation | - | - | - | - | 1件: 97 97 💬
|
122 | Felzartamab | 1件: Felzartamab Felzartamab | - | - | - | 2件: 66 66, 222 💬
|
123 | Femoston 1/10 | - | - | - | - | 1件: 13 13 💬
|
124 | Femoston 2/10 | - | - | - | - | 1件: 13 13 💬
|
125 | Fendrix suspension FOR injection | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 💬
|
126 | Fendrix, suspensióN inyectable | - | - | - | - | 1件: 97 97 💬
|
127 | Fenebrutinib | 1件: Fenebrutinib Fenebrutinib | 1件: Fenebrutinib
Fenebrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 1件: 13 13 💬
|
128 | Fenfluramina cloridrato | 1件: Fenfluramine Fenfluramine | 2件: Fenfluramine hydrochloride
Fenfluramine hydrochloride
,
Fenfluramine
💬
| 5件: HTR1 HTR1, HTR2, HTR2, SIGMAR1, SLC6A4 💬
| 11件: Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬 | 2件: 140 140, 144 💬
|
129 | Fenfluramine | 1件: Fenfluramine Fenfluramine | 2件: Fenfluramine hydrochloride
Fenfluramine hydrochloride
,
Fenfluramine
💬
| 5件: HTR1 HTR1, HTR2, HTR2, SIGMAR1, SLC6A4 💬
| 11件: Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬 | 4件: 140 140, 144, 145, 149 💬
|
130 | Fenfluramine HCL, DL-fenfluramine, (±)-fenfluramine | 1件: Fenfluramine Fenfluramine | 2件: Fenfluramine hydrochloride
Fenfluramine hydrochloride
,
Fenfluramine
💬
| 5件: HTR1 HTR1, HTR2, HTR2, SIGMAR1, SLC6A4 💬
| 11件: Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬 | 1件: 144 144 💬
|
131 | Fenfluramine hydrochloride | 1件: Fenfluramine Fenfluramine | 2件: Fenfluramine hydrochloride
Fenfluramine hydrochloride
,
Fenfluramine
💬
| 5件: HTR1 HTR1, HTR2, HTR2, SIGMAR1, SLC6A4 💬
| 11件: Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬 | 2件: 140 140, 144 💬
|
132 | Fengshigutong capsule plus imrecoxib | - | - | - | - | 1件: 271 271 💬
|
133 | Fenilbutirato | - | - | - | - | 1件: 2 2 💬
|
134 | Fenofibrate | 1件: Fenofibrate Fenofibrate | 1件: Fenofibrate
Fenofibrate
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 6件: 8 8, 79, 93, 94, 97, 265 💬
|
135 | Fenofibrate 160MG | 1件: Fenofibrate Fenofibrate | 1件: Fenofibrate
Fenofibrate
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 97 97 💬
|
136 | Fenofibrate 200MG | 1件: Fenofibrate Fenofibrate | 1件: Fenofibrate
Fenofibrate
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 💬
|
137 | Fenofibrate combined with ursodeoxycholic acid | 2件: Fenofibrate Fenofibrate, Ursodeoxycholic acid | 2件: Fenofibrate
Fenofibrate
,
Ursodiol
💬
| 2件: NR1C1 NR1C1, NR1H4 💬
| 11件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 💬
|
138 | Fenofibrate IN combination with ursodeoxycholic acid | 1件: Fenofibrate Fenofibrate | 1件: Fenofibrate
Fenofibrate
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 💬
|
139 | Fenretinide | 1件: Fenretinide Fenretinide | 1件: Fenretinide
Fenretinide
💬
| 2件: RARA RARA, RARB 💬
| 8件: Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 299 299 💬
|
140 | Fentanyl | 1件: Fentanyl Fentanyl | 3件: Fentanyl
Fentanyl
,
Fentanyl citrate
,
Fentanyl hydrochloride
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 5件: 46 46, 70, 97, 231, 298 💬
|
141 | Fentanyl (LOW dose) + dexmedetomidine | 1件: Fentanyl Fentanyl | 3件: Fentanyl
Fentanyl
,
Fentanyl citrate
,
Fentanyl hydrochloride
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 215 215 💬
|
142 | Fentanyl B. braun | 1件: Fentanyl Fentanyl | 3件: Fentanyl
Fentanyl
,
Fentanyl citrate
,
Fentanyl hydrochloride
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
143 | Fentanyl transdermal patch | 1件: Fentanyl Fentanyl | 3件: Fentanyl
Fentanyl
,
Fentanyl citrate
,
Fentanyl hydrochloride
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
144 | Feraccru | 1件: Ferric maltol Ferric maltol | 1件: Ferric maltol
Ferric maltol
💬
| - | - | 1件: 97 97 💬
|
145 | Feraheme | - | - | - | - | 1件: 13 13 💬
|
146 | Feramyl | - | - | - | - | 1件: 97 97 💬
|
147 | Ferinject | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 3件: 86 86, 97, 299 💬
|
148 | Ferinject - 50 MG/ML soluzione iniettabile O PER infusione 1 flaconcino IN vetro DA 10 ML | - | - | - | - | 1件: 97 97 💬
|
149 | Ferinject 50 MG /ML. solucióN inyectable Y para perfusióN | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 1件: 97 97 💬
|
150 | Ferinject 50 MG eisen/ML | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 1件: 97 97 💬
|
151 | Ferinject 50 MG iron/ML solution FOR injection and infusion | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 1件: 97 97 💬
|
152 | Ferinject or cosmofer | - | - | - | - | 1件: 86 86 💬
|
153 | Ferlixit - 62.5 MG/5 ML soluzione PER USO orale E USO endovenoso 5 fiale DA 5 ML | - | - | - | - | 1件: 97 97 💬
|
154 | Fermented oyster extract | - | - | - | - | 1件: 84 84 💬
|
155 | Ferracru | - | - | - | - | 1件: 97 97 💬
|
156 | Ferric carboxy maltose | - | - | - | - | 2件: 96 96, 97 💬
|
157 | Ferric carboxymaltose | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 4件: 86 86, 96, 97, 299 💬
|
158 | Ferric derisomaltose | 1件: Ferric derisomaltose Ferric derisomaltose | 1件: Ferric derisomaltose
Ferric derisomaltose
💬
| - | - | 1件: 97 97 💬
|
159 | Ferric gluconate | 1件: Ferrous gluconate Ferrous gluconate | 2件: Ferric gluconate
Ferric gluconate
,
Ferrous gluconate
💬
| - | - | 1件: 97 97 💬
|
160 | Ferric maltol | 1件: Ferric maltol Ferric maltol | 1件: Ferric maltol
Ferric maltol
💬
| - | - | 2件: 96 96, 97 💬
|
161 | Ferric trimaltol | - | - | - | - | 1件: 97 97 💬
|
162 | Ferricarboxymaltose | - | - | - | - | 1件: 86 86 💬
|
163 | Ferriprox | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 1件: 121 121 💬
|
164 | Ferriprox 500 MG | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 1件: 6 6 💬
|
165 | Ferriprox*100CPR RIV 500MG | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 1件: 121 121 💬
|
166 | Ferrisat | - | - | - | - | 1件: 97 97 💬
|
167 | Ferrisat 50MG/ML | - | - | - | - | 1件: 97 97 💬
|
168 | Ferro duretter, prolonged release tablet | - | - | - | - | 1件: 97 97 💬
|
169 | Ferro E.V. (come carbossimaltoso ferrico) - ferinject | - | - | - | - | 1件: 97 97 💬
|
170 | Ferrofumaraat apotex | - | - | - | - | 1件: 97 97 💬
|
171 | Ferrofumaraat teva | - | - | - | - | 1件: 97 97 💬
|
172 | Ferrograd folic tablets | - | - | - | - | 1件: 46 46 💬
|
173 | Ferrous fumarate | 1件: Ferrous fumarate Ferrous fumarate | - | - | - | 1件: 97 97 💬
|
174 | Ferrous fumarate syrup | 1件: Ferrous fumarate Ferrous fumarate | - | - | - | 1件: 97 97 💬
|
175 | Ferrous sulfate 325MG | - | - | - | - | 1件: 299 299 💬
|
176 | Ferrous sulfate tablets | - | - | - | - | 1件: 97 97 💬
|
177 | Ferrous sulphate | - | - | - | - | 2件: 96 96, 97 💬
|
178 | Ferrous sulphate 200MG oral tablet | - | - | - | - | 1件: 227 227 💬
|
179 | Ferrous sulphate with 65 MG iron++ PER tablet | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
180 | Ferulic acid | 1件: Ferulic acid Ferulic acid | - | - | - | 1件: 127 127 💬
|
181 | Ferumoxytol | 1件: Ferumoxytol Ferumoxytol | 1件: Ferumoxytol
Ferumoxytol
💬
| - | - | 2件: 13 13, 226 💬
|
182 | Ferumoxytol infusion | 1件: Ferumoxytol Ferumoxytol | 1件: Ferumoxytol
Ferumoxytol
💬
| - | - | 1件: 13 13 💬
|
183 | Fesoterodine | 1件: Fesoterodine Fesoterodine | 2件: Fesoterodine
Fesoterodine
,
Fesoterodine fumarate
💬
| 2件: CHRM2 CHRM2, CHRM3 💬
| 14件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
184 | Fetal porcine cells, neurocell-PD | - | - | - | - | 1件: 6 6 💬
|
185 | Fexofenadine | 1件: Fexofenadine Fexofenadine | 2件: Fexofenadine hydrochloride
Fexofenadine hydrochloride
,
Fexofenadine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 4件: 6 6, 13, 19, 46 💬
|
186 | FFP104 | - | - | - | - | 2件: 93 93, 96 💬
|
187 | FG-3019 | - | - | - | - | 3件: 85 85, 113, 222 💬
|
188 | FG-3019 10MG/ML IN 10 ML vials | - | - | - | - | 1件: 85 85 💬
|
189 | Fibrate treatment | - | - | - | - | 1件: 160 160 💬
|
190 | Fibrin | 1件: Fibrin Fibrin | - | - | - | 1件: 279 279 💬
|
191 | Fibrin adhesive | 1件: Fibrin Fibrin | - | - | - | 1件: 97 97 💬
|
192 | Fibrin glue injection IN fistula | 1件: Fibrin Fibrin | - | - | - | 1件: 96 96 💬
|
193 | Fibrinogen | 1件: Fibrinogen human Fibrinogen human | 1件: Fibrinogen I 125
Fibrinogen I 125
💬
| - | - | 1件: 107 107 💬
|
194 | Fibrinogen concentrate | 1件: Fibrinogen human Fibrinogen human | 1件: Fibrinogen I 125
Fibrinogen I 125
💬
| - | - | 1件: 14 14 💬
|
195 | Fibrinogen concentrate from human plasma | 1件: Fibrinogen human Fibrinogen human | 1件: Fibrinogen I 125
Fibrinogen I 125
💬
| - | - | 1件: 65 65 💬
|
196 | Fibrinogen plasma concentration, coagulation factor xiii activity | 1件: Fibrinogen human Fibrinogen human | 1件: Fibrinogen I 125
Fibrinogen I 125
💬
| - | - | 1件: 288 288 💬
|
197 | Fibrinogen TO albumin ratio and C-reactive TO albumin ratio | 1件: Fibrinogen human Fibrinogen human | 1件: Fibrinogen I 125
Fibrinogen I 125
💬
| - | - | 1件: 49 49 💬
|
198 | Fibrogammin | - | - | - | - | 1件: 288 288 💬
|
199 | Fibrogammin P | - | - | - | - | 1件: 288 288 💬
|
200 | Fibrogammin® 1250 | - | - | - | - | 1件: 51 51 💬
|
201 | Fibrogammin® P | - | - | - | - | 1件: 288 288 💬
|
202 | Fibrogammin®P | - | - | - | - | 1件: 288 288 💬
|
203 | Fibroscan | - | - | - | - | 1件: 171 171 💬
|
204 | Fibrovein | - | - | - | - | 1件: 279 279 💬
|
205 | Fidaxomicin | 1件: Fidaxomicin Fidaxomicin | 1件: Fidaxomicin
Fidaxomicin
💬
| - | - | 1件: 97 97 💬
|
206 | Fidaxomicina | 1件: Fidaxomicin Fidaxomicin | 1件: Fidaxomicin
Fidaxomicin
💬
| - | - | 1件: 97 97 💬
|
207 | Fidrisertib | 1件: Fidrisertib Fidrisertib | 1件: Fidrisertib
Fidrisertib
💬
| 1件: ACVR1 ACVR1 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hormone signaling, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | 1件: 272 272 💬
|
208 | Fidrisertib (IPN60130) 10 MG capsules | 1件: Fidrisertib Fidrisertib | 1件: Fidrisertib
Fidrisertib
💬
| 1件: ACVR1 ACVR1 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hormone signaling, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | 1件: 272 272 💬
|
209 | Fidrisertib (IPN60130) 50 MG capsules | 1件: Fidrisertib Fidrisertib | 1件: Fidrisertib
Fidrisertib
💬
| 1件: ACVR1 ACVR1 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hormone signaling, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | 1件: 272 272 💬
|
210 | Fidsertib | - | - | - | - | 1件: 272 272 💬
|
211 | FIG | 1件: Fig Fig | - | - | - | 1件: 2 2 💬
|
212 | Filgotinib | 1件: Filgotinib Filgotinib | 2件: Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 10件: 46 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬
|
213 | Filgotinib 200MG/DAY | 1件: Filgotinib Filgotinib | 2件: Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬
|
214 | Filgotinib maleate | 1件: Filgotinib Filgotinib | 2件: Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 2件: 46 46, 97 💬
|
215 | Filgrastim | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 29件: 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
|
216 | Filgrastim hexal | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 65 65 💬
|
217 | FILM-coated tablet | - | - | - | - | 2件: 96 96, 97 💬
|
218 | Filsuvez | - | - | - | - | 1件: 36 36 💬
|
219 | Fimepinostat | 1件: Fimepinostat Fimepinostat | 1件: Fimepinostat
Fimepinostat
💬
| 11件: HDAC10 HDAC10, HDAC1_2, HDAC1_2, HDAC3, HDAC4_5, HDAC4_5, HDAC6, HDAC7, HDAC8, HDAC9, PIK3C3 💬
| 32件: ATP-dependent chromatin remodeling ATP-dependent chromatin remodeling, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Inositol phosphate metabolism, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phagosome, Phosphatidylinositol signaling system, Polycomb repressive complex, Salmonella infection, Shigellosis, Spinocerebellar ataxia, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis 💬 | 1件: 75 75 💬
|
220 | Finamine tablets | - | - | - | - | 1件: 6 6 💬
|
221 | Finasteride | 1件: Finasteride Finasteride | 1件: Finasteride
Finasteride
💬
| 1件: SRD5A2 SRD5A2 💬
| 2件: Prostate cancer Prostate cancer, Steroid hormone biosynthesis 💬 | 1件: 6 6 💬
|
222 | Finely ground flaxseed powder | - | - | - | - | 1件: 299 299 💬
|
223 | Finerenone | 1件: Finerenone Finerenone | 1件: Finerenone
Finerenone
💬
| 1件: NR3C2 NR3C2 💬
| 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 4件: 66 66, 218, 222, 224 💬
|
224 | Fingolimob | - | - | - | - | 1件: 13 13 💬
|
225 | Fingolimod | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 14, 156 💬
|
226 | Fingolimod 0.5 MG | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
227 | Fingolimod 0.5MG | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
228 | Fingolimod 1.25 MG | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
229 | Fingolimod hydrochloride | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 14 💬
|
230 | Fingolimodi | - | - | - | - | 1件: 13 13 💬
|
231 | Fingolmod | - | - | - | - | 1件: 13 13 💬
|
232 | Fipamezole | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 💬
|
233 | Fipamezole hydrochloride 30 MG oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 💬
|
234 | Fipamezole hydrochloride 60 MG oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 💬
|
235 | Fipamezole hydrochloride 90 MG oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 💬
|
236 | Fipamezole ODT | 1件: Fipamezole Fipamezole | - | - | - | 1件: 6 6 💬
|
237 | Fipamezole ODT cohort 2 | 1件: Fipamezole Fipamezole | - | - | - | 1件: 6 6 💬
|
238 | Firategrast | 1件: Firategrast Firategrast | 1件: Firategrast
Firategrast
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
239 | Firategrast 150 MG | 1件: Firategrast Firategrast | 1件: Firategrast
Firategrast
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
240 | Firategrast 300 MG | 1件: Firategrast Firategrast | 1件: Firategrast
Firategrast
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
241 | Firategrast gastro-retentive solution | 1件: Firategrast Firategrast | 1件: Firategrast
Firategrast
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
242 | Firategrast immediate release tablet | 1件: Firategrast Firategrast | 1件: Firategrast
Firategrast
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
243 | Firategrast modified release tablet | 1件: Firategrast Firategrast | 1件: Firategrast
Firategrast
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
244 | Firazyr | 1件: Icatibant Icatibant | 1件: Icatibant acetate
Icatibant acetate
💬
| 1件: BDKRB2 BDKRB2 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬
|
245 | Firazyr (icatibant) 30 MG solution FOR injection IN PRE filled syringe | 1件: Icatibant Icatibant | 1件: Icatibant acetate
Icatibant acetate
💬
| 1件: BDKRB2 BDKRB2 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬
|
246 | Firazyr 30 MG solucióN inyectable EN jeringa precargada | 1件: Icatibant Icatibant | 1件: Icatibant acetate
Icatibant acetate
💬
| 1件: BDKRB2 BDKRB2 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬
|
247 | Firazyr 30 MG solution FOR injection IN PRE-filled syringe | 1件: Icatibant Icatibant | 1件: Icatibant acetate
Icatibant acetate
💬
| 1件: BDKRB2 BDKRB2 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬
|
248 | Firazyr*SC 1SIR 30MG 3ml10MG/M | 1件: Icatibant Icatibant | 1件: Icatibant acetate
Icatibant acetate
💬
| 1件: BDKRB2 BDKRB2 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬
|
249 | Firazyr® 30 MG subcutaneous injection syringe: 3.0 ML×1 syringe | 1件: Icatibant Icatibant | 1件: Icatibant acetate
Icatibant acetate
💬
| 1件: BDKRB2 BDKRB2 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬
|
250 | Firdapse - 10 MG - compresse - USO orale - blister(ALU/PVC/pvdc) 100 X 1 compresse | - | - | - | - | 2件: 3 3, 11 💬
|
251 | First line DMT | - | - | - | - | 1件: 13 13 💬
|
252 | First-line biologic:IFX | - | - | - | - | 1件: 97 97 💬
|
253 | First-line biologic:VDZ | - | - | - | - | 1件: 97 97 💬
|
254 | First-line cognitive assessment | - | - | - | - | 1件: 3 3 💬
|
255 | Fisetin | 1件: Fisetin Fisetin | - | - | - | 1件: 65 65 💬
|
256 | Fish assay | - | - | - | - | 1件: 28 28 💬
|
257 | Fish intake | - | - | - | - | 1件: 46 46 💬
|
258 | Fish OIL | 1件: Fish oil Fish oil | - | - | - | 5件: 13 13, 46, 49, 96, 299 💬
|
259 | Fish OIL capsule | 1件: Fish oil Fish oil | - | - | - | 1件: 79 79 💬
|
260 | Fish OIL concentrate | 1件: Fish oil Fish oil | - | - | - | 1件: 13 13 💬
|
261 | Fish OIL supplement | 1件: Fish oil Fish oil | - | - | - | 1件: 46 46 💬
|
262 | Fish OIL, gamma-linolenic acid | 1件: Fish oil Fish oil | - | - | - | 1件: 46 46 💬
|
263 | Fish OIL, rich IN omega-3-acids | 1件: Fish oil Fish oil | - | - | - | 1件: 13 13 💬
|
264 | Fish OIL,rich IN omega 3 acids | 1件: Fish oil Fish oil | - | - | - | 1件: 13 13 💬
|
265 | Fitbit activity monitor | - | - | - | - | 1件: 49 49 💬
|
266 | FITC-adalimumab | - | - | - | - | 2件: 96 96, 97 💬
|
267 | Fixed dose combination ciprofloxacin/celecoxib | - | - | - | - | 1件: 2 2 💬
|
268 | FK-506 | - | - | - | - | 1件: 60 60 💬
|
269 | FK506 | - | - | - | - | 1件: 222 222 💬
|
270 | FK506 level 2-3 NG/ML | - | - | - | - | 1件: 86 86 💬
|
271 | FK506 level 3-5 NG/ML | - | - | - | - | 1件: 86 86 💬
|
272 | FK506 level < 2 NG/ML | - | - | - | - | 1件: 86 86 💬
|
273 | FKB327 | - | - | - | - | 1件: 46 46 💬
|
274 | FKB327 AI | - | - | - | - | 1件: 46 46 💬
|
275 | FKB327 PFS | - | - | - | - | 1件: 46 46 💬
|
276 | FKC288 | - | - | - | - | 1件: 222 222 💬
|
277 | Flagyl | 1件: Metronidazole Metronidazole | 2件: Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | 2件: 96 96, 97 💬
|
278 | Flash glucose monitoring system | - | - | - | - | 1件: 49 49 💬
|
279 | Flavocoxid | - | - | - | - | 1件: 113 113 💬
|
280 | Flavoxate | 1件: Flavoxate Flavoxate | 2件: Flavoxate hydrochloride
Flavoxate hydrochloride
,
Flavoxate
💬
| 16件: PDE1 PDE1, PDE1, PDE1, PDE10, PDE11, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE7, PDE7, PDE8, PDE8 💬
| 17件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 💬
|
281 | Flebogamma 5% DIF | - | - | - | - | 1件: 65 65 💬
|
282 | Flecainide + BETA-blocker | 1件: Flecainide Flecainide | 2件: Flecainide acetate
Flecainide acetate
,
Flecainide
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 115 115 💬
|
283 | Flecainide acetate | 1件: Flecainide Flecainide | 2件: Flecainide acetate
Flecainide acetate
,
Flecainide
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 6 6 💬
|
284 | Flecainidum | 1件: Flecainide Flecainide | 2件: Flecainide acetate
Flecainide acetate
,
Flecainide
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 6 6 💬
|
285 | Flexibility and postural exercise | - | - | - | - | 1件: 299 299 💬
|
286 | Flexibility and strengthening exercise | - | - | - | - | 1件: 6 6 💬
|
287 | Flixabi | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
288 | Flolan injection with currently marketed diluent | - | - | - | - | 1件: 86 86 💬
|
289 | Flolan injection with reformulated diluent | - | - | - | - | 1件: 86 86 💬
|
290 | Flolan TM and glycine diluent | 1件: Epoprostenol Epoprostenol | 2件: Epoprostenol
Epoprostenol
,
Epoprostenol sodium
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬
|
291 | Flolan™ and glycine diluent | 1件: Epoprostenol Epoprostenol | 2件: Epoprostenol
Epoprostenol
,
Epoprostenol sodium
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬
|
292 | Florbetapir 18F | - | - | - | - | 1件: 127 127 💬
|
293 | Florbetapir 18F injection | - | - | - | - | 1件: 127 127 💬
|
294 | Florbetapir F 18 | - | - | - | - | 1件: 6 6 💬
|
295 | Florence 30 µG/ML | - | - | - | - | 1件: 98 98 💬
|
296 | Florence 60 µG/ML | - | - | - | - | 1件: 98 98 💬
|
297 | Florence 90 µG/ML | - | - | - | - | 1件: 98 98 💬
|
298 | Flortaucipir F18 | 1件: Flortaucipir Flortaucipir | 1件: Flortaucipir F 18
Flortaucipir F 18
💬
| 1件: MAPT MAPT 💬
| 4件: Alzheimer disease Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | 3件: 5 5, 7, 127 💬
|
299 | Floseal | - | - | - | - | 1件: 227 227 💬
|
300 | Flovent | - | - | - | - | 1件: 98 98 💬
|
301 | Flow cytometry | - | - | - | - | 6件: 28 28, 41, 51, 60, 65, 285 💬
|
302 | FLOW-mediated dilation OF THE brachial artery | - | - | - | - | 1件: 49 49 💬
|
303 | FLT190 | 1件: FLT190 FLT190 | - | - | - | 1件: 19 19 💬
|
304 | FLT201 | 1件: FLT201 FLT201 | - | - | - | 1件: 19 19 💬
|
305 | FLU-ATG | - | - | - | - | 1件: 60 60 💬
|
306 | FLU/CY/ATG or CY/ATG | - | - | - | - | 1件: 60 60 💬
|
307 | Flucinolone acetonide | - | - | - | - | 1件: 56 56 💬
|
308 | Flucloxacillin | 1件: Flucloxacillin Flucloxacillin | 2件: Flucloxacillin sodium
Flucloxacillin sodium
,
Floxacillin
💬
| - | - | 1件: 299 299 💬
|
309 | Flucloxacillin 250MG/5ML sugar-free powder FOR oral solution | 1件: Flucloxacillin Flucloxacillin | 2件: Flucloxacillin sodium
Flucloxacillin sodium
,
Floxacillin
💬
| - | - | 1件: 299 299 💬
|
310 | Flucloxacillin sodium | 1件: Flucloxacillin Flucloxacillin | 2件: Flucloxacillin sodium
Flucloxacillin sodium
,
Floxacillin
💬
| - | - | 1件: 299 299 💬
|
311 | Flucloxicillin | - | - | - | - | 1件: 299 299 💬
|
312 | Fluconazole | 1件: Fluconazole Fluconazole | 1件: Fluconazole
Fluconazole
💬
| - | - | 2件: 96 96, 225 💬
|
313 | Fludara | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
314 | Fludarabina accord | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 65 65 💬
|
315 | Fludarabina accord - 25 MG/ML concentrato PER soluzione iniettabile O PER infusione 5 flaconcini IN vetro DA 2 ML | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 19 19 💬
|
316 | Fludarabina fosfato | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 19 19 💬
|
317 | Fludarabina teva - 25 MG/ML concentrato PER soluzione iniettabile O PER infusione 1 flaconcino DI vetro DA 2 ML | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 65 65 💬
|
318 | Fludarabine | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 23件: 11 11, 13, 19, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 326 💬
|
319 | Fludarabine monophosphate | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 3件: 65 65, 284, 326 💬
|
320 | Fludarabine phosphate | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 12件: 28 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286 💬
|
321 | Fludarabine phosphate 30 MG | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 2件: 65 65, 164 💬
|
322 | Fludarabine phosphate 40 MG | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 2件: 65 65, 164 💬
|
323 | Fludarabine phosphate FOR injection | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
324 | Fludarabine, busulfan, thymoglobulin | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 65 65 💬
|
325 | Fludarabine, cyclophosphamide | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 60 60 💬
|
326 | Fludarabine, melphalan, thiotepa | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 65 65 💬
|
327 | Fludarabine/ melphalan | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 60 60 💬
|
328 | Fludarabine/busulfan | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 60 60 💬
|
329 | Fludeoxyglucose | 1件: Fludeoxyglucose Fludeoxyglucose | - | - | - | 1件: 88 88 💬
|
330 | Fludeoxyglucose F 18 | 2件: Fludeoxyglucose Fludeoxyglucose, Fludeoxyglucose (18F) | 1件: Fludeoxyglucose F 18
Fludeoxyglucose F 18
💬
| - | - | 1件: 34 34 💬
|
331 | Fludrocortisone | 1件: Fludrocortisone Fludrocortisone | 2件: Fludrocortisone acetate
Fludrocortisone acetate
,
Fludrocortisone
💬
| 1件: NR3C2 NR3C2 💬
| 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 3件: 6 6, 17, 81 💬
|
332 | Fluid biopsy capsule | - | - | - | - | 1件: 6 6 💬
|
333 | Fluid restriction | - | - | - | - | 1件: 72 72 💬
|
334 | Fluimucil | - | - | - | - | 1件: 193 193 💬
|
335 | Fluimucil*20CPR EFF 600MG | - | - | - | - | 2件: 94 94, 298 💬
|
336 | Fluimucil® 600 MG effervescent tablets | - | - | - | - | 1件: 85 85 💬
|
337 | Flumazenil | 1件: Flumazenil Flumazenil | 1件: Flumazenil
Flumazenil
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 5件: 6 6, 13, 17, 18, 206 💬
|
338 | Fluocinolone acetonide | 2件: Fluocinolone Fluocinolone, Fluocinolone acetonide | 1件: Fluocinolone acetonide
Fluocinolone acetonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 💬
|
339 | Fluorescein | 1件: Fluorescein Fluorescein | 2件: Fluorescein
Fluorescein
,
Fluorescein sodium
💬
| - | - | 2件: 22 22, 97 💬
|
340 | Fluorescein and indocyanine green angiography | 1件: Fluorescein Fluorescein | 2件: Fluorescein
Fluorescein
,
Fluorescein sodium
💬
| - | - | 1件: 41 41 💬
|
341 | Fluorescein angiography | 1件: Fluorescein Fluorescein | 2件: Fluorescein
Fluorescein
,
Fluorescein sodium
💬
| - | - | 2件: 19 19, 41 💬
|
342 | Fluorescence imaging | - | - | - | - | 2件: 46 46, 97 💬
|
343 | Fluorescence IN situ hybridization | - | - | - | - | 1件: 285 285 💬
|
344 | Fluorescence molecular imaging procedure using vedolizumab-800CW with prior administration OF unlabeled vedolizumab | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
345 | Fluorescence molecular imaging procedure without prior administration OF vedolizumab-800CW | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
346 | Fluorescite | - | - | - | - | 1件: 215 215 💬
|
347 | Fluorine (18F) fludeoxyglucose | - | - | - | - | 1件: 84 84 💬
|
348 | Fluorine F 18 clofarabine | - | - | - | - | 4件: 40 40, 46, 49, 96 💬
|
349 | Fluorine-18 | 1件: Fluorine F-18 Fluorine F-18 | 1件: Sodium fluoride F 18
Sodium fluoride F 18
💬
| - | - | 1件: 41 41 💬
|
350 | Fluoro[18F]promethazine | - | - | - | - | 1件: 6 6 💬
|
351 | Fluorodeoxyglucose | - | - | - | - | 1件: 84 84 💬
|
352 | Fluoroscopic swallow evaluation | - | - | - | - | 1件: 6 6 💬
|
353 | Fluoroscopy | - | - | - | - | 1件: 6 6 💬
|
354 | Fluoxetin hexal | 1件: Fluoxetine Fluoxetine | 2件: Fluoxetine
Fluoxetine
,
Fluoxetine hydrochloride
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
355 | Fluoxetine | 1件: Fluoxetine Fluoxetine | 2件: Fluoxetine
Fluoxetine
,
Fluoxetine hydrochloride
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 3件: 13 13, 17, 86 💬
|
356 | Fluoxetine hydrochloride | 1件: Fluoxetine Fluoxetine | 2件: Fluoxetine
Fluoxetine
,
Fluoxetine hydrochloride
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
357 | Fluoxétine | 1件: Fluoxetine Fluoxetine | 2件: Fluoxetine
Fluoxetine
,
Fluoxetine hydrochloride
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 17 17 💬
|
358 | Flupentixol | 1件: Flupentixol Flupentixol | 3件: Flupentixol
Flupentixol
,
Flupentixol dihydrochloride
,
Flupentixol decanoate
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 97 97 💬
|
359 | Flupirtin | - | - | - | - | 1件: 13 13 💬
|
360 | Flupirtine | 1件: Flupirtine Flupirtine | 2件: Flupirtine maleate
Flupirtine maleate
,
Flupirtine
💬
| - | - | 1件: 13 13 💬
|
361 | Flupirtinmaleat | - | - | - | - | 1件: 13 13 💬
|
362 | Flurbiprofen | 1件: Flurbiprofen Flurbiprofen | 2件: Flurbiprofen
Flurbiprofen
,
Flurbiprofen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 3件: 13 13, 21, 46 💬
|
363 | Flutamide | 1件: Flutamide Flutamide | 1件: Flutamide
Flutamide
💬
| 1件: AR AR 💬
| 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 81 81 💬
|
364 | Flutemetamol | 1件: Flutemetamol Flutemetamol | - | - | - | 4件: 5 5, 6, 7, 127 💬
|
365 | Flutemetamol F18 injection | 2件: Flutemetamol Flutemetamol, Flutemetamol (18F) | 1件: Flutemetamol F 18
Flutemetamol F 18
💬
| - | - | 5件: 5 5, 6, 7, 17, 127 💬
|
366 | Fluticasone | 1件: Fluticasone Fluticasone | 1件: Fluticasone
Fluticasone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 98 98, 228, 299 💬
|
367 | Fluticasone MDI | 1件: Fluticasone Fluticasone | 1件: Fluticasone
Fluticasone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
368 | Fluticasone propionate | 2件: Fluticasone Fluticasone, Fluticasone propionate | 2件: Fluticasone propionate
Fluticasone propionate
,
Fluticasone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 98 98, 228, 306 💬
|
369 | Fluticasone propionate, USP | 2件: Fluticasone Fluticasone, Fluticasone propionate | 2件: Fluticasone propionate
Fluticasone propionate
,
Fluticasone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
370 | Fluvastatin | 1件: Fluvastatin Fluvastatin | 2件: Fluvastatin sodium
Fluvastatin sodium
,
Fluvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 2件: 79 79, 222 💬
|
371 | Fluzone | - | - | - | - | 1件: 49 49 💬
|
372 | FLX-787-ODT | - | - | - | - | 1件: 2 2 💬
|
373 | FMP-30 | - | - | - | - | 1件: 53 53 💬
|
374 | FMT | - | - | - | - | 3件: 96 96, 97, 271 💬
|
375 | FMT enema | - | - | - | - | 1件: 97 97 💬
|
376 | FMT infusions | - | - | - | - | 1件: 97 97 💬
|
377 | FMT oral | - | - | - | - | 1件: 97 97 💬
|
378 | FMT protocol | - | - | - | - | 1件: 97 97 💬
|
379 | FNP-223 | - | - | - | - | 1件: 5 5 💬
|
380 | Focetria | - | - | - | - | 3件: 46 46, 49, 271 💬
|
381 | FOG | - | - | - | - | 1件: 6 6 💬
|
382 | Folacin | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 2件: 96 96, 97 💬
|
383 | Folate | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 2件: 41 41, 46 💬
|
384 | Folic (or folinic) acid | - | - | - | - | 1件: 46 46 💬
|
385 | Folic acid | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 6件: 46 46, 84, 96, 97, 172, 296 💬
|
386 | Folic acid 1 MG | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 1件: 6 6 💬
|
387 | Folic acid or folate | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 1件: 46 46 💬
|
388 | Folic acid tablet | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 1件: 6 6 💬
|
389 | Folic acid, vitamin B6, vitamin B12 | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 1件: 6 6 💬
|
390 | Folic/folinic acid | - | - | - | - | 2件: 46 46, 107 💬
|
391 | Foliglurax | 1件: Foliglurax Foliglurax | - | - | - | 1件: 6 6 💬
|
392 | Folimet | - | - | - | - | 1件: 46 46 💬
|
393 | Folinic acid | 1件: Leucovorin Leucovorin | 3件: Leucovorin calcium
Leucovorin calcium
,
Folinic acid
,
Folinic acid calcium salt pentahydrate
💬
| - | - | 2件: 46 46, 320 💬
|
394 | Follow-UP study OF THE treated cohort | - | - | - | - | 1件: 193 193 💬
|
395 | Follow-UP study OF THE untreated cohort | - | - | - | - | 1件: 193 193 💬
|
396 | Fontolizumab | 1件: Fontolizumab Fontolizumab | 1件: Fontolizumab
Fontolizumab
💬
| 1件: IFNG IFNG 💬
| 32件: African trypanosomiasis African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 46 46 💬
|
397 | Food diary | - | - | - | - | 1件: 65 65 💬
|
398 | Food groups and nutrients | - | - | - | - | 1件: 46 46 💬
|
399 | Foralumab | 1件: Foralumab Foralumab | - | - | - | 2件: 13 13, 96 💬
|
400 | Foralumab nasal | 1件: Foralumab Foralumab | - | - | - | 1件: 17 17 💬
|
401 | Foralumab TZLS-401 100 µG | 1件: Foralumab Foralumab | - | - | - | 1件: 13 13 💬
|
402 | Foralumab TZLS-401 50 µG | 1件: Foralumab Foralumab | - | - | - | 1件: 13 13 💬
|
403 | Fordadistrogene movaparvovec | 1件: Fordadistrogene movaparvovec Fordadistrogene movaparvovec | - | - | - | 1件: 113 113 💬
|
404 | Forigerimod | 1件: Forigerimod Forigerimod | 1件: Forigerimod
Forigerimod
💬
| - | - | 1件: 49 49 💬
|
405 | Forlax 4 G, poudre pour solution buvable EN sachet | - | - | - | - | 1件: 299 299 💬
|
406 | Formalin-fixed paraffin-embedded (ffpe) tissue samples analysis | 1件: Formaldehyde Formaldehyde | 1件: Formaldehyde
Formaldehyde
💬
| - | - | 1件: 98 98 💬
|
407 | Formistin - 10 MG compresse rivestite CON film 20 compresse | - | - | - | - | 1件: 13 13 💬
|
408 | Formistin 10 MG | - | - | - | - | 1件: 13 13 💬
|
409 | Formoterol | 1件: Formoterol Formoterol | 2件: Formoterol fumarate
Formoterol fumarate
,
Formoterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 306 306 💬
|
410 | Formoterol fumarate dihydrate | 1件: Formoterol Formoterol | 2件: Formoterol fumarate
Formoterol fumarate
,
Formoterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
411 | Formoterol/budesonide | 1件: Formoterol Formoterol | 2件: Formoterol fumarate
Formoterol fumarate
,
Formoterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 💬
|
412 | Formula | - | - | - | - | 1件: 96 96 💬
|
413 | Formulation A | - | - | - | - | 1件: 13 13 💬
|
414 | Formulation B | - | - | - | - | 1件: 13 13 💬
|
415 | Formulation C | - | - | - | - | 1件: 13 13 💬
|
416 | Formulation D | - | - | - | - | 1件: 13 13 💬
|
417 | Forsteo | 1件: Teriparatide Teriparatide | 3件: Teriparatide acetate
Teriparatide acetate
,
Teriparatide
,
Teriparatide acetate
💬
| 1件: PTH1R PTH1R 💬
| 4件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 3件: 70 70, 235, 274 💬
|
418 | Forsteo-R | - | - | - | - | 1件: 235 235 💬
|
419 | Fortecortin | - | - | - | - | 1件: 28 28 💬
|
420 | Forteo | 1件: Teriparatide Teriparatide | 3件: Teriparatide acetate
Teriparatide acetate
,
Teriparatide
,
Teriparatide acetate
💬
| 1件: PTH1R PTH1R 💬
| 4件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 70 70 💬
|
421 | Forteo 20 MG | - | - | - | - | 1件: 235 235 💬
|
422 | Fortiral | - | - | - | - | 1件: 6 6 💬
|
423 | Fortum | - | - | - | - | 1件: 299 299 💬
|
424 | Forxiga | 1件: Dapagliflozin Dapagliflozin | 1件: Dapagliflozin
Dapagliflozin
💬
| - | - | 2件: 86 86, 88 💬
|
425 | FOS | - | - | - | - | 2件: 66 66, 96 💬
|
426 | Foscarbidopa | 1件: Foscarbidopa Foscarbidopa | 1件: Foscarbidopa
Foscarbidopa
💬
| - | - | 1件: 6 6 💬
|
427 | Foscarbidopa and foslevodopa | 2件: Foscarbidopa Foscarbidopa, Foslevodopa | 2件: Foslevodopa
Foslevodopa
,
Foscarbidopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
428 | Foscarnet | 1件: Foscarnet Foscarnet | 1件: Foscarnet sodium
Foscarnet sodium
💬
| - | - | 1件: 60 60 💬
|
429 | Foscarnet sodium | 1件: Foscarnet Foscarnet | 1件: Foscarnet sodium
Foscarnet sodium
💬
| - | - | 2件: 28 28, 60 💬
|
430 | Fosd | - | - | - | - | 1件: 46 46 💬
|
431 | Fosfamatinib disodium | - | - | - | - | 1件: 46 46 💬
|
432 | Fosfato sodico DE dexametasona | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
433 | Fosfomycin | 1件: Fosfomycin Fosfomycin | 3件: Fosfomycin tromethamine
Fosfomycin tromethamine
,
Fosfomycin sodium
,
Fosfomycin
💬
| - | - | 2件: 96 96, 97 💬
|
434 | Fosigotifator | 1件: Fosigotifator Fosigotifator | 1件: Fosigotifator
Fosigotifator
💬
| 5件: EIF2B1 EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 💬
| 1件: Herpes simplex virus 1 infection Herpes simplex virus 1 infection 💬 | 2件: 2 2, 308 💬
|
435 | Foslevodopa | 1件: Foslevodopa Foslevodopa | 1件: Foslevodopa
Foslevodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
436 | Fosmetpantotenate | - | - | - | - | 1件: 121 121 💬
|
437 | Fosmetpantotenate drug substance | - | - | - | - | 1件: 121 121 💬
|
438 | Fosmetpantotenato | - | - | - | - | 1件: 121 121 💬
|
439 | Fospropofol (lusedra®) 10 | 1件: Fospropofol Fospropofol | 1件: Fospropofol disodium
Fospropofol disodium
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 226 226 💬
|
440 | Fospropofol (lusedra®) 6.5 | 1件: Fospropofol Fospropofol | 1件: Fospropofol disodium
Fospropofol disodium
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 226 226 💬
|
441 | Fostair | - | - | - | - | 1件: 85 85 💬
|
442 | Fostamatinib | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 3件: 46 46, 49, 63 💬
|
443 | Fostamatinib 100 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
444 | Fostamatinib 100 MG tablet | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
445 | Fostamatinib 150 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
446 | Fostamatinib 150 MG BID | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 61 61 💬
|
447 | Fostamatinib 150 MG tablet | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
448 | Fostamatinib 50 MG blue FILM-coated tablet | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬
|
449 | Fostamatinib disodium | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 4件: 46 46, 61, 63, 66 💬
|
450 | Fostamatinib disodium / R935788 | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 63 63 💬
|
451 | Fostamatinib disodium 100 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 63 63 💬
|
452 | Fostamatinib disodium 150 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 63 63 💬
|
453 | Fostamatinib disodium tablet 100 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
454 | Fostamatinib disodium tablet 150 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
455 | Fostamatinib disodium tablets | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 63 63 💬
|
456 | Four square step test | - | - | - | - | 2件: 6 6, 13 💬
|
457 | FP-045 | - | - | - | - | 1件: 285 285 💬
|
458 | FP-110 | - | - | - | - | 1件: 97 97 💬
|
459 | FP-CYA-050 | - | - | - | - | 1件: 97 97 💬
|
460 | FP-CYA-053 | - | - | - | - | 1件: 97 97 💬
|
461 | FPA008 | - | - | - | - | 1件: 46 46 💬
|
462 | FPFS-1169 | - | - | - | - | 1件: 6 6 💬
|
463 | FPI-2620 | - | - | - | - | 1件: 127 127 💬
|
464 | FR104 | - | - | - | - | 1件: 46 46 💬
|
465 | Fractionated carbon dioxide (FCO2) laser | - | - | - | - | 1件: 50 50 💬
|
466 | Fragment antibody targeting human TFR1 conjugated TO phosphorodiamidate morpholino oligomer | - | - | - | - | 1件: 113 113 💬
|
467 | Fragmin | 1件: Dalteparin Dalteparin | 1件: Dalteparin sodium
Dalteparin sodium
💬
| 1件: SERPINC1 SERPINC1 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 222 222 💬
|
468 | Frameshift array blood sample test | - | - | - | - | 1件: 34 34 💬
|
469 | Free amino acids intake | - | - | - | - | 1件: 240 240 💬
|
470 | Free diet | - | - | - | - | 1件: 97 97 💬
|
471 | Freeze dried grape powder | - | - | - | - | 2件: 96 96, 97 💬
|
472 | Freeze-dried black raspberry powder | - | - | - | - | 1件: 97 97 💬
|
473 | Fremanezumab | 1件: Fremanezumab Fremanezumab | 1件: Fremanezumab
Fremanezumab
💬
| 1件: CALC CALC 💬
| 3件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬 | 2件: 124 124, 226 💬
|
474 | Fresh frozen plasma | - | - | - | - | 2件: 5 5, 14 💬
|
475 | Fresolimumab | 1件: Fresolimumab Fresolimumab | 1件: Fresolimumab
Fresolimumab
💬
| 3件: TGFB1 TGFB1, TGFB2, TGFB3 💬
| 36件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, Efferocytosis, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | 3件: 51 51, 222, 274 💬
|
476 | Frexalimab | 1件: Frexalimab Frexalimab | 1件: Frexalimab
Frexalimab
💬
| 1件: TNFSF5 TNFSF5 💬
| 14件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 💬 | 2件: 13 13, 222 💬
|
477 | Frisium*30CPS 10MG | - | - | - | - | 1件: 140 140 💬
|
478 | FRM-0334 | - | - | - | - | 1件: 127 127 💬
|
479 | Frondanol | - | - | - | - | 1件: 97 97 💬
|
480 | Froniglutide | 1件: Froniglutide Froniglutide | - | - | - | 1件: 50 50 💬
|
481 | Fructose | 1件: Fructose Fructose | 1件: Fructose
Fructose
💬
| - | - | 1件: 179 179 💬
|
482 | Fructose and galactose | 1件: Fructose Fructose | 1件: Fructose
Fructose
💬
| - | - | 1件: 257 257 💬
|
483 | Fructose sachet | 1件: Fructose Fructose | 1件: Fructose
Fructose
💬
| - | - | 1件: 97 97 💬
|
484 | Fruit and vegetables intake | - | - | - | - | 1件: 46 46 💬
|
485 | Fruit juice | - | - | - | - | 1件: 299 299 💬
|
486 | FSME-immun | - | - | - | - | 1件: 46 46 💬
|
487 | FT-002 | - | - | - | - | 1件: 90 90 💬
|
488 | FT011 100 MG | - | - | - | - | 1件: 51 51 💬
|
489 | FT011 200 MG | - | - | - | - | 1件: 51 51 💬
|
490 | FT819 | - | - | - | - | 2件: 49 49, 51 💬
|
491 | FTI, azli | - | - | - | - | 1件: 299 299 💬
|
492 | FTX-1821 | - | - | - | - | 1件: 113 113 💬
|
493 | FTY720 | - | - | - | - | 1件: 13 13 💬
|
494 | FTY720D | - | - | - | - | 1件: 13 13 💬
|
495 | FTY720I | - | - | - | - | 1件: 14 14 💬
|
496 | Fucidin tablets | 1件: Fusidic acid Fusidic acid | 2件: Fusidic acid
Fusidic acid
,
Fusidic acid hemihydrate
💬
| - | - | 1件: 299 299 💬
|
497 | Full history , clinical examination, assesment OF disease activity ,laboratory investigations ( CBC , ESR, CRP serum creatinine and blood urea, random plas | - | - | - | - | 2件: 46 46, 49 💬
|
498 | Full spectrum vitamin | - | - | - | - | 1件: 13 13 💬
|
499 | Fully human ANTI-interferon gamma monoclonal antibody | - | - | - | - | 1件: 107 107 💬
|
500 | Fully human IGG1 monoclonal antibody specific FOR TL1A | - | - | - | - | 2件: 96 96, 97 💬
|
501 | Fully human IGG2 lambda monoclonal antibody | - | - | - | - | 1件: 172 172 💬
|
502 | Fully human monoclonal antibody directed against CXCL10 | - | - | - | - | 1件: 93 93 💬
|
503 | Fully humanized ANTI-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody | - | - | - | - | 1件: 13 13 💬
|
504 | Fultium-D3 800IU capsules | - | - | - | - | 1件: 274 274 💬
|
505 | Fulvestrant | 1件: Fulvestrant Fulvestrant | 1件: Fulvestrant
Fulvestrant
💬
| 2件: ESR1 ESR1, ESR2 💬
| 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 86 86 💬
|
506 | Fumaderm® initial | - | - | - | - | 1件: 49 49 💬
|
507 | Functional and antigenic C1 inhibitor | - | - | - | - | 1件: 65 65 💬
|
508 | Functional assessment questionnaires | - | - | - | - | 1件: 41 41 💬
|
509 | Functional balance intervention | - | - | - | - | 1件: 13 13 💬
|
510 | Functional hepatic nitrogen clearance | - | - | - | - | 1件: 171 171 💬
|
511 | Functional index-2 | - | - | - | - | 1件: 113 113 💬
|
512 | Functional involvement OF identified epigenetic alterations | - | - | - | - | 1件: 102 102 💬
|
513 | Functional magnetic resonance imaging | - | - | - | - | 1件: 6 6 💬
|
514 | Functional mobility | - | - | - | - | 2件: 6 6, 13 💬
|
515 | Functional oral intake scale | - | - | - | - | 1件: 2 2 💬
|
516 | Functional reach test | - | - | - | - | 2件: 6 6, 13 💬
|
517 | Functional residual capacity | - | - | - | - | 1件: 294 294 💬
|
518 | Fundus autofluorescence | - | - | - | - | 1件: 41 41 💬
|
519 | Furestem-RA INJ | - | - | - | - | 1件: 46 46 💬
|
520 | Furosemide | 1件: Furosemide Furosemide | 1件: Furosemide
Furosemide
💬
| 1件: SLC12A2 SLC12A2 💬
| 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 2件: 77 77, 86 💬
|
521 | Furosemide injection | 1件: Furosemide Furosemide | 1件: Furosemide
Furosemide
💬
| 1件: SLC12A2 SLC12A2 💬
| 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 1件: 6 6 💬
|
522 | Fursultiamine | 1件: Fursultiamine Fursultiamine | 2件: Fursultiamine
Fursultiamine
,
Fursultiamine hydrochloride
💬
| - | - | 1件: 6 6 💬
|
523 | Fusidic acid | 1件: Fusidic acid Fusidic acid | 2件: Fusidic acid
Fusidic acid
,
Fusidic acid hemihydrate
💬
| - | - | 1件: 299 299 💬
|
524 | Fusidin | - | - | - | - | 1件: 299 299 💬
|
525 | Fuzhenghuayu | - | - | - | - | 1件: 93 93 💬
|
526 | FX-1006A | 1件: Fx-1006A Fx-1006A | - | - | - | 1件: 28 28 💬
|
527 | FX125L | - | - | - | - | 1件: 46 46 💬
|
528 | Fxiia inhibitor monoclonal antibody | - | - | - | - | 2件: 65 65, 85 💬
|
529 | Fycompa | 1件: Perampanel Perampanel | 2件: Perampanel
Perampanel
,
Perampanel hydrate
💬
| 4件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬
| 17件: Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 2件: 2 2, 144 💬
|